T0A.F TRULIEVE CANNABIS

Healthcare Pharmaceuticals Frankfurt Exchange
8.75 EUR
Close of Nov 12, 2026
4.02 11.10
Market cap
EUR 1.49B
P/E
-
P/B
2.40x
ROE
-69.4%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is T0A.F undervalued?

Graham number

The Graham number of TRULIEVE CANNABIS cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

TRULIEVE CANNABIS fundamental analysis

No fundamental analysis for TRULIEVE CANNABIS yet.

TRULIEVE CANNABIS stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About TRULIEVE CANNABIS

Trulieve Cannabis Corp. operates as a cannabis retailer in the United States. The company cultivates, processes, and manufactures cannabis products and distributes its products to its dispensaries, as well as through home delivery. It sells flowers, edibles, vapes, oral, topical, concentrates, and accessories under the Avenue, Cultivar Collection, Muse, Modern Flower, Alchemy, Momenta, Sweet Talk, Co2lors, and Roll One brands. The company operates dispensaries in Florida, Ar…

Full company profile